Fig. 3From: Genome editing via non-viral delivery platforms: current progress in personalized cancer therapySchematic examples showing different applications of lipid-based delivery system for GETs. a CRISPR-Cas9 genome editing complexed with targeted lipid nanoparticles inhibit the growth of glioblastoma ovarian tumors. b Combing CRISPR-Cas9 with lipid nanoparticles for the tissue-specific gene editing or the generation of tumor modelsBack to article page